Effect of 2% dorzolamide on retinal blood flow: a study on juvenile primary open-angle glaucoma patients already receiving 0.5% timolol

Br J Clin Pharmacol. 2007 Mar;63(3):376-9. doi: 10.1111/j.1365-2125.2006.02768.x. Epub 2006 Sep 19.

Abstract

Aim: To investigate whether dorzolamide modifies peripapillary retinal haemodynamics in juvenile primary open-angle glaucoma (JPOAG) patients treated with timolol.

Methods: In 40 JPOAG subjects, before and after dorzolamide coadministration with timolol, the following examinations were achieved: intraocular pressure (IOP), blood pressure (BP), ocular perfusion pressure (OPP), heart rate (HR), visual field and retinal flowmetry.

Results: Adjunctive therapy with dorzolamide induced the following modifications: IOP reduction [1.75 mmHg, 95% confidence interval (CI) 1.23, 2.26; P < 0.05], OPP increase (5.09 mmHg, 95% CI 2.97, 7.20; P < 0.02) and retinal blood flow improvement (35.0 arbitrary units, 95% CI 12.20, 57.80; P < 0.03). BP, HR and visual field indices did not change.

Conclusions: Dorzolamide, in association or in fixed combination with timolol, significantly improves retinal blood flow in JPOAG patients.

MeSH terms

  • Adolescent
  • Adrenergic beta-Antagonists / therapeutic use*
  • Adult
  • Carbonic Anhydrase Inhibitors / therapeutic use*
  • Drug Interactions
  • Female
  • Glaucoma, Open-Angle / drug therapy*
  • Humans
  • Intraocular Pressure / drug effects
  • Male
  • Middle Aged
  • Regional Blood Flow / drug effects
  • Sulfonamides / therapeutic use*
  • Thiophenes / therapeutic use*
  • Timolol / therapeutic use*

Substances

  • Adrenergic beta-Antagonists
  • Carbonic Anhydrase Inhibitors
  • Sulfonamides
  • Thiophenes
  • Timolol
  • dorzolamide